PRLNers, so our speculations are revealed.
Finally, we can stop this dietary supplement madness. I was never a big fan of this approach anyway. I truly hope that the company moves back into their clinical plan, if, as others have pointed out, they have the cash to do so. I am distubed that they are "exploring other potential near-term commercialization options relative to Andrographis paniculata and other compounds..." This is crap. What a waste of effort, unless they are looking to outside the U.S.? And what makes our tiny company think it can market overseas?
Remember way back before the plans of dietary supplements, PRLN was trading at 5 times its current level based on promising clinical and pre-clinical data for PN27,1 and PN355. Ah, the "good old days" when we PRLNers were all young and foolish.
What REALLY disturbs me is that, once again, the investors were deceived. When did they FDA inform PRLN? Why the release now? What does Rhodes mean by "...we have determined that it would not be economically viable to introduce these products as dietary supplements for the general population."? The "economically viable" part is irrelevant, the FDA will simply not allow it, they would be prosecuted by the federal government if they try to sell it. Why couldn'y Rhodes put a positive spin on this, i.e.,
"Although the data show that AndroVir and AndroCar are safe and well-tolerated, the FDA has indicated that clincial results, which demonstrate the AIDS viral load recution activity and anti-tumor activity for the two compounds, respectively, preclude the possibility of marketing as dietary supplments.
Upon the FDA advisory, we are cancelling our dietary supplment strategy for AndroVir anbd Andro Car at this time. We are currently exploring other options for marketing outside the U.S. as dietary supplements, and continued clinical trials in the U.S."
Did Keith write this release or what? Which is better, his or mine? Is anyone out there bailing out now?
Rick C |
